Therapeutic Options to Prevent Severe COVID-19 in Immunocompromised People

The U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUA) for monoclonal antibodies to treat COVID-19 for certain patients. Clinicians will learn the FDA’s role in issuing EUAs for certain monoclonal antibodies, options for compassionate use, the process for ordering and distributing monoclonal antibodies, and current data on using monoclonal antibodies for both non-hospitalized and immunocompromised patients. Presenters will also cover preventing, diagnosing, and treating COVID-19 in immunocompromised patients, including the role of monoclonal antibodies, serologic testing, and potential third dose of COVID-19 vaccinations.

This video can also be viewed at

Recommend0 recommendationsPublished in national-health-agency-sources

Related Articles

5 Essential Frameworks for Preventing Violent Child Death

The U.S. has a violent child death problem. Developing strategies to prevent violent child deaths death from firearms and traffic crashes is a demanding task that requires consideration of numerous upstream, interrelated, and tangential issues. To help safety advocates develop strategies to prevent violent child death, we compiled five frameworks to help: Understand and explain …
The post 5 Essential Frameworks for Preventing Violent Child Death appeared first on Salud America.

FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision

The U.S. Food and Drug Administration approved a new drug called Aduhelm (aducanumab) to treat Alzheimer’s disease, the most common form of dementia. Many are applauding the drug and are encouraged by the scientific progress in a field that has long had limited treatment options. Alzheimer’s affects over 6.2 million people in the U.S., with …
The post FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision appeared first on Salud America.

What Latino Parents Should Know: COVID-19 Vaccinations Authorized for Children Under 5

Big news for Latino parents – the Moderna and the Pfizer-BioNTech COVID-19 vaccines have been authorized for children between ages 6 months and 5 years. The CDC now recommends everyone 6 months or older to get vaccinated against COVID-19. Those 5 years of age and older are also recommended to get a COVID-19 vaccine booster, …
The post What Latino Parents Should Know: COVID-19 Vaccinations Authorized for Children Under 5 appeared first on Salud America.

What Are the Risk and Protective Factors for Violent Child Death?

Gun violence and traffic crashes may seem like unpredictable events. But they are not random. They are systematic. Data reveal trends and patterns in gun violence and traffic crashes that can help us identify risk factors and protective factors. This is especially important for addressing violent child deaths. So what does the data show? Join …
The post What Are the Risk and Protective Factors for Violent Child Death? appeared first on Salud America.

How Do I Safely Use a Multi-Dose Vaccine Vial?

Many vaccines, including the current vaccines for COVID-19, come in small bottles with more than one dose inside. These are known as multiple-dose, or “multi-dose” vials, and can be used to vaccinate more than one patient. Multi-Dose Vials and Infection Control Multi-dose vials are more likely to become contaminated compared to single-dose vials, and therefore …
The post How Do I Safely Use a Multi-Dose Vaccine Vial? appeared first on Salud America.

Responses